“…Furthermore, sleep quality can be objectively assessed through actigraphy: sleep disturbance is indicated by a total sleep time (TST) of ⩽6.5 h (Lacks and Morin, 1992), sleep efficiency (SE) of ⩽85% (Coates et al , 1982), sleep onset latency (SOL) of >30 min (Espie et al , 2001), or wake after sleep onset (WASO) of >30 min (Savard and Morin, 2001). Factors including age (Kim et al , 2000; Chen et al , 2015b), sex, marital status (Baiden et al , 2015), cancer stage, and anticancer treatments (Roscoe et al , 2007; Chen et al , 2015b), which can affect sleep quality, must be included in sleep quality assessments for cancer patients. Unstable rest-activity rhythms lead to sleep disturbance (Miaskowski and Lee, 1999; Berger et al , 2007), and non-small-cell lung cancer patients with disrupted rest-activity rhythms may experience poor sleep quality and insomnia (Levin et al , 2005).…”